Name	REVERSE T3
Description	Reverse T3 (3,3',5'-triiodo-L-thyronine) inhibits the increase of sodium current generated by other thyroid hormone analogs in neonatal rat myocytes.
Cell Research	Brain death (BD) was induced in mechanically ventilated rats by inflation of a Fogarty catheter in the epidural space.?T3 (0.1 mg/kg) or vehicle was administered intraperitoneally 2 h prior to BD induction.?After 4 h of BD, serum and liver tissue were collected.?RT-qPCR, routine biochemistry, and immunohistochemistry were performed[1].
In vitro	Reverse T3(T3) pre-conditioning leads to beneficial effects in the liver of brain-dead rats as seen by lower cellular injury and reduced apoptosis, and supports the suggested role of reverse T3(T3) hormone therapy in the management of brain-dead donors[1].
Storage	store at low temperature \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Solubility Information	DMSO : 17.76 mg/mL (27.28 mM), Sonication is recommended.
Keywords	Thyroidhormonereceptor(THR) \| Thyroidhormonereceptor \| Thyroid hormone receptor(THR) \| Thyroid Hormone Receptor \| Thyroid hormone receptor \| Thyroid hormone \| THR \| REVERSE T-3 \| REVERSE T3 \| Reverse T 3 \| Inhibitor \| inhibit \| 3′,5′,3-Triiodothyronine
Inhibitors Related	Azetirelin \| L-Thyroxine \| L-Thyroxine sodium \| Resmetirom \| 2,2-BIS(2-HYDROXY-5-BIPHENYLYL)PROPANE \| Iopanoic acid \| Carbimazole \| Octinoxate \| Methimazole \| 2-Thiouracil \| PCO371 \| Tiratricol

REVERSE T3 NEW

Product Introduction